Table 2.
Technical and procedural success, periprocedural complications, and 12-month major adverse events in stent and no-stent groups.
| Demographic and Clinical Characteristics | All (n = 2910) | Stent based (n = 1339) | Non-Stent Based (n = 1171) | P-Value |
|---|---|---|---|---|
| Technical success | 2763 (95.0%) | 1328 (99.1%) | 1435 (91.3%) | <.001 |
| Procedure success | 2706 (93.0%) | 1293 (96.6%) | 1413 (89.9%) | <.001 |
| Procedural complications | ||||
| Residual dissection | 84 (2.9%) | 48 (3.6%) | 36 (2.3%) | .04 |
| Access-site hematoma | 17 (0.6%) | 10 (0.8%) | 7 (0.5%) | .29 |
| Retroperitoneal hematoma | 9 (0.3%) | 7 (0.5%) | 2 (0.1%) | .06 |
| Bleeding diathesis | 3 (0.1%) | 3 (0.2%) | 0 (0.0%) | .60 |
| Distal embolization | 37 (1.3%) | 20 (1.5%) | 17 (1.1%) | .32 |
| Acute renal failure | 5 (0.2%) | 4 (0.3%) | 1 (0.1%) | .13 |
| Perforation | 15 (0.5%) | 7 (0.5%) | 8 (0.5%) | .96 |
| Emergency surgery | 4 (0.2%) | 1 (0.1%) | 3 (0.2%) | .37 |
| Death | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | - |
| Amputation | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | - |
| 12-month adverse eventsa | ||||
| Death | 48 (2.2%) | 22 (2.2%) | 26 (2.3%) | .92 |
| Non-fatal myocardial infarction | 47 (1.6%) | 21 (1.6%) | 26 (1.7%) | .85 |
| Stroke | 8 (0.3%) | 2 (0.2%) | 6 (0.4%) | .23 |
| Target-limb revascularization | 417 (14.3%) | 201 (15.0%) | 216 (13.8%) | .33 |
| Endovascular | 361 (12.4%) | 169 (12.6%) | 192 (12.2%) | .74 |
| Surgical | 64 (2.2%) | 36 (2.7%) | 28 (1.8%) | .10 |
| Target-vessel revascularization | 360 (12.4%) | 169 (12.6%) | 191 (12.2%) | .70 |
| Target-limb amputation | 127 (4.4%) | 54 (4.0%) | 73 (4.7%) | .42 |
| Major | 54 (1.9%) | 21 (1.6%) | 33 (2.1%) | .29 |
| Minor | 82 (2.8%) | 37 (2.8%) | 45 (2.9%) | .87 |
Data presented as number (%).
Based on 2162 patients (2910 procedures) with completed 1-year follow-up. P-values based on Chi-square statistics.